Building an Effective Value Proposition for an Early Stage Product
CBI Early Stage Commercialization Conference, Philadelphia
November 13, 2007Chairperson and Speaker for Maximizing the Value of Your Partnering and Business Development Efforts
November 12, 2007The Role of the Payer and the Patient in the Development and Marketing of Biotech Products
U. of California, Berkeley Haas Business School
November 5, 2007Expanding the Value of Lifecycle Management Efforts
Pharmaceutical Executive Sales and Marketing Summit, Philadelphia
October 25, 2007Healogix CEO to speak at EyeForPharma conference in Barcelona
Healogix Founder and CEO to be a featured speaker at the upcoming Early Commercialisation, Lifecycle & Portfolio Management conference, October 25-26, 2007, at the Barcelo Hotel Sants in Barcelona, Spain.
July 17, 2007Pharmaceutical Executive's Marketing and sales Summit 2007
Healogix to Present at Pharmaceutical Executive’s Marketing and Sales Summit 2007
May 15, 2007Healogix article appears in this month's BioExecutive International
Look for Harris Kaplan's article, "Consumer Empowerment Meets Marketing Savvy" in this month's issue or download it here
February 26, 2007Performing Future Product Valuation Before Development to Improve Commercial Success
Harris Kaplan and John O'Brien to speak at CBI Early Stage Product Development and Commercialization Strategies Conference
December 12, 2006The Pharma and Biotech Industry: The perspective of the Payer and the Patient
The Berkeley Biotech Conference featured a number of industry thought leaders on the topics of product development and commercialization, forecasting, launch support and marketing. It was attended by numerous biotech participants as well as investors, venture groups, and consultants.
December 6, 2006Developing New Products
Healogix CEO, Harris Kaplan, and Kim Slocum's speech at CBI's Pharmaceutical Product Launches discussed the new imperatives facing pharmaceutical developers and marketers. Among those: integrate the views of all the stakeholders, not just what it takes to gain physician acceptance.
October 25, 2006Building Better Labels, Claims and Positioning
Hear the webinar, where Healogix CEO Harris Kaplan and Genentech Head of Respiratory Franchise Martin Babler discuss the collaboration required between the R&D function and the commercial functions if a product is to be truly successful in gaining uptake.
September 26, 2006Gauging New Products' Potential
Healogix CEO, Harris Kaplan, presents a new methodology for assessing the potential commercial success of a drug, based on the label/claims that will be shown to the marketplace.
The innovation: this assessment can take place before Phase III trials so that clinical development plans can be revised to better align the drug for market success.